You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1308 Artificial intelligence (AI)-powered immune phenotyping based on programmed death ligand 1 (PD-L1) immunohistochemistry (IHC) in triple negative breast cancer (TNBC)

Citation Tools

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Machine Learning, Artificial Intelligence and Computational Modeling
1308 Artificial intelligence (AI)-powered immune phenotyping based on programmed death ligand 1 (PD-L1) immunohistochemistry (IHC) in triple negative breast cancer (TNBC)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Shin S, Park G, Cho SI, et al
1308 Artificial intelligence (AI)-powered immune phenotyping based on programmed death ligand 1 (PD-L1) immunohistochemistry (IHC) in triple negative breast cancer (TNBC)
Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.1308